EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment

Haiyao Hu, Chong'en Sun, Jingyao Chen, Zhengyu Li

Journal of Cancer Research and Clinical Oncology · 20.03.2024 · 150 (3)

DOI: 10.1007/s00432-024-05654-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cancer Research and Clinical Oncology, online erschienen am 20.03.2024. Verfasst von Haiyao Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Gynecology. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian cancer (OC) is a major cause of gynecological cancer mortality, necessitating enhanced research. Organoids, cellular clusters grown in 3D model, have emerged as a disruptive paradigm, transcending the limitations inherent to conventional models by faithfully recapitulating key morphological, histological, and genetic attributes. This review undertakes a comprehensive exploration of the potential in organoids derived from murine, healthy population, and patient origins, encompassing a spectrum that spans foundational principles to pioneering applications. Organoids serve as preclinical models, allowing us to predict how patients will respond to treatments and guiding the development of personalized therapies. In the context of evaluating new drugs, organoids act as versatile platforms, enabling thorough testing of innovative combinations and novel agents. Remarkably, organoids mimic the dynamic nature of OC progression, from its initial formation to the spread to other parts of the body, shedding light on intricate details that hold significant importance. By functioning at an individualized level, organoids uncover the complex mechanisms behind drug resistance, revealing strategic opportunities for effective treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsGynecologyHumansFemaleAnimalsMicePrecision MedicineOrganoids

Stichwörter der Autor:innen

Cancer modelingOrganoidOvarian cancerPrecision medicine

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
  • Key Laboratory of Obstetrics and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.
  • State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China. zhengyuli01@126.com.
  • Key Laboratory of Obstetrics and Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China. zhengyuli01@126.com.

Förderung

  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Hu, H., Sun, C., Chen, J., & Li, Z. (2024). Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment. Journal of Cancer Research and Clinical Oncology, 150(3). https://doi.org/10.1007/s00432-024-05654-0

Vancouver

Hu H, Sun C, Chen J, Li Z. Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment. Journal of Cancer Research and Clinical Oncology. 2024;150(3). doi:10.1007/s00432-024-05654-0

BibTeX
@article{Hu2024,
  author = {Hu, Haiyao and Sun, Chong'en and Chen, Jingyao and Li, Zhengyu},
  title = {Organoids in ovarian cancer: a platform for disease modeling, precision medicine, and drug assessment},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  volume = {150},
  number = {3},
  doi = {10.1007/s00432-024-05654-0}
}
Kostenlos starten →